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Introduction
Several debilitating diseases are caused by mutations in mi-
tochondrial dynamics genes. Mutations in the mitochondrial 
fusion genes Mfn2 and Opa1 cause Charcot-Marie-Tooth 
neuropathy type 2A and dominant optic atrophy, respectively 
(Alexander et al., 2000; Delettre et al., 2000; Züchner et al., 
2004). For mitochondrial fission, a Drp1 mutation has been 
shown to cause widespread neurological dysfunction and neo-
natal lethality (Waterham et al., 2007), and an Mff mutation 
has been found in two brothers with neuromuscular defects 
(Shamseldin et al., 2012).
In cultured cells, the balance between mitochondrial fusion 
and fission regulates mitochondrial morphology (Friedman and 
Nunnari, 2014; Mishra and Chan, 2014). This observation sug-
gests that pharmacological agents that up- or down-regulate mi-
tochondrial dynamics may have therapeutic value. Antagonists 
of mitochondrial fission have been developed (Cassidy-Stone et 
al., 2008; Qi et al., 2013) and may, in principle, benefit condi-
tions associated with impaired mitochondrial fusion. To evalu-
ate the feasibility of this approach, it is important to determine 
whether whole-organ physiology can be restored by resetting 
an optimal balance between mitochondrial fusion and fission.
In this study, we show that mice lacking the mitochondrial 
fission gene Mff die at ∼13 wk as a result of dilated cardio-
myopathy. Mff is a mitochondrial and peroxisomal membrane 
protein that is a major receptor for Drp1, the effector of fission 
(Gandre-Babbe and van der Bliek, 2008; Otera et al., 2010; 
Losón et al., 2013). Heart-specific Drp1-null mice have a se-
vere cardiac phenotype and die at 1–1.5 wk (Kageyama et al., 
2014; Ishihara et al., 2015). Acute removal of Drp1 from adult 
heart similarly results in rapid heart failure (Ikeda et al., 2015; 
Song et al., 2015). Interestingly, removal of the mitochondrial 
fusion genes Mfn1 and Mfn2 also causes cardiac defects (Chen 
et al., 2011; Papanicolaou et al., 2012; Kasahara et al., 2013; 
Dorn et al., 2015; Song et al., 2015). Given the demonstrated 
importance of both mitochondrial fusion and fission in cardio-
myocytes, we reasoned that the heart would be an ideal organ 
system to study how retuning of mitochondrial dynamics in 
vivo might regulate tissue physiology.
Defects in mitochondrial fusion or fission are associated with many pathologies, raising the hope that pharmacological 
manipulation of mitochondrial dynamics may have therapeutic benefit. This approach assumes that organ physiology 
can be restored by rebalancing mitochondrial dynamics, but this concept remains to be validated. We addressed this 
issue by analyzing mice deficient in Mff, a protein important for mitochondrial fission. Mff mutant mice die at 13 wk as 
a result of severe dilated cardiomyopathy leading to heart failure. Mutant tissue showed reduced mitochondrial density 
and respiratory chain activity along with increased mitophagy. Remarkably, concomitant deletion of the mitochondrial 
fusion gene Mfn1 completely rescued heart dysfunction, life span, and respiratory chain function. Our results show for 
the first time that retuning the balance of mitochondrial fusion and fission can restore tissue integrity and mitochondrial 
physiology at the whole-organ level. Examination of liver, testis, and cerebellum suggest, however, that the precise bal-
ance point of fusion and fission is cell type specific.
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Results and discussion
Mff-deficient mice exhibit pleiotropic 
phenotypes
To examine the physiological role of Mff in mammals, we 
generated mice with a gene trap disruption of Mff (Fig. S1 A). 
Western blot analysis confirmed the lack or vast reduction of all 
Mff isoforms in homozygous gene trap (Mffgt) cells and tissues 
(Fig. S1, B and C). Loss of Mff resulted in a notable decrease in 
Drp1 and moderate reductions in other mitochondrial dynamics 
proteins (Fig. S1 D). The latter may result from a generalized 
reduction of mitochondria (see Fig. 4).
Mffgt mice die prematurely with a mean life span of 13 wk 
(Fig. 1 A). The reduced life span results from dilated cardiomy-
opathy, as detailed in the following section. Mutants are notably 
smaller than their wild-type littermates (Fig. S1, E and F). In 
contrast to mitochondrial fusion–deficient mice that have met-
abolic signs of increased glycolysis (Chen et al., 2010), the Mff 
mutants have normal temperature, lactate, and glucose levels 
(Fig. S1 G). Mutants also suffer from malocclusion and kypho-
sis with incomplete penetrance (Fig. S1, H and I).
Mffgt mice demonstrate prominent neuromuscular defects. 
Their gait is altered, showing a side-to-side wobble and high 
step with a lowered tail (Video 1). Mutants also have decreased 
grasping ability (Fig. S1 J). Fertility of Mffgt mice is decreased 
in both males and females (Fig. S1 K). In males, this reduced 
fertility is associated with reduced sperm count (Fig. S1 L).
Finally, Mffgt mice demonstrate an altered immunological 
profile, with increased amounts of IgG heavy chain in tissues 
(Fig. S2 A). Whole blood contains normal IgG levels (Fig. S2 
B), suggesting that IgG deposition, not production, is increased.
Dilated cardiomyopathy leads to 
heart failure
The early lethality of Mffgt mice is caused by dilated cardio-
myopathy, leading to heart failure. Both atria and ventricles 
are notably enlarged in 13–14-wk-old mutants (Fig.  1  B). 
Cross sections show that whereas the lumens are expanded, 
the heart walls are thinner. As expected in dilated cardiomyop-
athy, heart weight (normalized to tibia length) does not differ 
between wild-type and mutant mice despite the larger size of 
mutant hearts (Fig. 1 C).
End-stage myocardium shows disruption of the myofibril 
architecture by dramatic interstitial fibrosis (Fig. 1 D). Fibroblast 
proliferation can be detected by 4 wk of age. Subsequent collagen 
deposition, detected by Masson's trichrome staining, appears as 
wisps of blue from 6 to 8 wk of age and broad bands at late stages. 
Fibrosis is a common hallmark of human cardiomyopathies. The 
replacement of cardiomyocytes by fibroblasts and collagen dis-
rupts myocardial structure and interferes with heart contractility 
(Harvey and Leinwand, 2011). Because fibrosis is generally con-
sidered a sequela to myocardiocyte death, we performed TUN EL 
staining to investigate the apoptotic rate. We found a threefold in-
crease in apoptosis in Mffgt hearts (Fig. 1, E and F), but the overall 
rate remains low and is unlikely to account for the fibrosis.
Although heart rate and rhythm remain largely unaffected, 
echocardiography confirms severe heart failure in 13–14-wk-old 
Mffgt mice (Fig. 1, G and H). M-mode readings expose a severe 
decrease in contraction of the left ventricular wall, resulting in 
an almost static left ventricle (LV) chamber volume throughout 
the cardiac cycle. Longitudinal experiments indicate that both 
fractional shortening and ejection fraction of the LV are fairly normal 
in 4–5-wk-old Mffgt mice. Thereafter, systolic function steadily 
deteriorates with age, culminating in heart failure (Fig. 1, I and J).
Deficient respiratory chain function in 
mitochondria of Mffgt heart
Cellular metabolism of cardiomyocytes predominantly relies on 
oxidative phosphorylation of fatty acids (Lopaschuk and Jaswal, 
2010). Respiration, measured by oxygen consumption rates of 
isolated heart mitochondria, is severely compromised in Mff 
mutants. By 6 wk of age, the mutant respiratory control ratio, 
the most useful indicator of mitochondrial function (Brand and 
Nicholls, 2011), is 50% that of the wild type (Fig. 2 A). Con-
sistent with reduced respiratory chain function, the steady-state 
level of ATP in end-stage Mffgt hearts is half that of the wild type 
(Fig. 2 B). At 8 wk, the difference in ATP is not yet statistically 
significant, suggesting that heart tissue can maintain overall 
ATP levels for a time even when respiratory capacity is com-
promised. It is likely, however, that sporadic cardiomyocytes 
can have reduced ATP and die, leading to a fibrotic response.
Histochemical analysis demonstrates reduced activity of 
respiratory complexes I (NADH dehydrogenase), II (succinate 
dehydrogenase [SDH]), and IV (cytochrome c oxidase [COX]) 
in Mff mutants (Fig.  2  C and Fig. S2 C). This profile is dis-
tinct from that of fusion-deficient mitochondria, where there is 
decreased NADH dehydrogenase and COX but increased SDH 
activity (Chen et al., 2007, 2010). The parallel loss of these ac-
tivities in Mffgt and Drp1−/− hearts (Kageyama et al., 2014; Ishi-
hara et al., 2015) suggests that the fission-deficient respiration 
defects are not caused by loss of mitochondrial DNA (mtDNA). 
Interestingly, metabolite profiling of mutant heart tissue re-
vealed a concurrent decrease in key Krebs cycle components 
(Fig. S2 D), supporting a generalized deficiency in energy pro-
duction in Mff-deficient mitochondria.
In contrast to Mffgt fibroblasts, which have dramatically 
elongated mitochondria (Losón et al., 2013), mutant cardiomy-
ocytes do not show a substantial change in mitochondrial length 
(Fig. 2, D and E). Instead, they demonstrate increased heteroge-
neity in mitochondrial shape and abundance (compare the two 
mutant images in Fig. 2 D).
Decreasing mitochondrial fusion rescues 
Mffgt lethality
Mffgt mice die at 13 wk of age. Mfn1-deficient mice (Mfn1loxP/loxP 
[Chen et al., 2007],Sox2-Cre [Hayashi et al., 2002]) die at birth 
(Fig. S2 E). Remarkably, when these two lethal mutations are 
combined, Mffgt,Mfn1loxP/−,Sox2-Cre double mutant animals 
(dm) demonstrate reciprocal rescue (Fig. 3 A and Fig. S2 E). 
In other words, ablating Mfn1 eliminates the cardiac-related le-
thality of Mffgt mice, and mutating Mff prevents the perinatal 
lethality of Mfn1-deficient mice. In fact, a cohort of 10 dm mice 
followed for over a year never exhibited signs of ill health.
The rescue by a mitofusin deletion strongly suggests 
that mitochondrial, rather than peroxisomal, defects cause the 
Mffgt cardiomyopathy. Peroxisomal shape was not changed in 
Mffgt cardiomyocytes (Fig. S2 F). Moreover, in Mffgt mouse 
embryonic fibroblasts (MEFs), both peroxisomes and mito-
chondria were highly elongated, and simultaneous removal of 
Mfn1 restored the morphology of mitochondria, but not peroxi-
somes (Fig. S2, G and H).
Interestingly, even single mutant alleles of either Mfn1 
or Mfn2 have a beneficial effect on the life span of Mffgt mice 
(Fig. 3 A). Using our original null alleles (Chen et al., 2003), 
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Figure 1. Cardiomyopathy in Mffgt mice. (A) Survival curve. Mffgt mutant (mut) mice (n = 22) die by 13 wk on average, as opposed to wild-type con-
trols (n = 14). (B) Increased size, dilation of chambers, and thinning of walls in mutant hearts. (C) Heart mass normalized to tibia length. (D) Masson’s 
trichrome stain of heart sections. Arrowheads indicate fibroblasts. Blue strands (arrows) denote collagen deposition. (E) TUN EL staining of heart sec-
tions. Arrows indicate apoptotic nuclei. (F) Quantification of apoptotic nuclei per field (n ≥ 11). (G) Heart rate (n ≥ 6). (H) M-mode echocardiogram of 
13–14-wk-old mice. Electrocardiogram is superimposed. (I and J) Longitudinal echocardiography measuring fractional shortening (I) and ejection fraction 
(J). Study conducted on 5 wild-type and 10 Mffgt mice (five mutants died during the course of the study). Error bars = SEM. *, P ≤ 0.01; **, P ≤ 0.001. 
Bars, 50 µm. WT, wild type.
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we determined that Mffgt,Mfn2+/− mice live to ∼17 wk, and 
Mffgt,Mfn1+/− mice live to ∼21 wk (60% life span extension). 
However, Mffgt,Mfn2loxP/−,Sox2-Cre double mutants die perina-
tally, as do Mfn2lox/loxP,Sox2-Cre single mutants. Thus, in direct 
contrast to the Mfn1 mutant, Mff deficiency cannot restore via-
bility to Mfn2-deficient mice.
To determine whether Mfn2 deletion in Mffgt mice can 
fully rescue the cardiomyopathy, we used the Myh6-Cre trans-
genic (Agah et al., 1997) to selectively ablate Mfn2 in the heart, 
thus circumventing the lethality caused by universal deletion 
of Mfn2. The Mffgt,Mfn2loxP/loxP,Myh6-Cre double mutants had a 
life span extension identical to that of Mffgt,Mfn2+/− mice (Fig. 
S2 I). Therefore, deletion of Mfn2 only modestly extends life 
span, whereas deletion of Mfn1 completely rescues the Mffgt 
cardiomyopathy. Collectively, these results show that the Mff 
cardiomyopathy can be rescued to differing degrees, depend-
ing on the Mfn gene and number of alleles removed. Therefore, 
optimal rescue requires precise titration of the levels of fusion.
Restoration of cardiac contractility, 
mitochondrial function, and cellular 
integrity in dm hearts
The life span extension observed in combining Mfn and Mff mu-
tations is associated with restoration of cardiac function, as in-
dicated by echocardiography of 13–14-wk-old mice (Fig. 3 B). 
Mff/Mfn1 mutants, whether Mfn1+/− or dm, exhibit fully normal 
cardiac contractility. Mffgt,Mfn2+/− mice, however, retain substan-
tial systolic dysfunction, consistent with the shorter life span of 
these mice. Histological analysis confirms tissue integrity of the 
myocardium in dm mice (Fig. 3 C). Surprisingly, dm cardiac mi-
Figure 2. Mitochondrial function and struc-
ture in Mffgt hearts. (A) Respiratory control 
ratio (ADP stimulated/endogenous) of isolated 
heart mitochondria. A significant decrease is 
observed at 6 wk (n = 2 samples; two mice/
sample) and ≥10 wk (three mutants; five wild 
types), but not at 4 wk (n = 3 samples; two 
mice/sample). (B) ATP levels in heart (n = 6). 
(C) Histochemical stains of mitochondrial res-
piration complex activities in hearts. Bar, 50 
µm. (D) EM of cardiomyocytes. Bars, 10 µm. 
(E) Mean mitochondrial length. Error bars = 
SEM. ^ , P ≤ 0.05; *, P ≤ 0.01. WT, wild type.
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Figure 3. Rescue of Mffgt phenotypes by deletion of Mfn1. (A) Survival curve demonstrating extension of life with loss of Mfn alleles (n ≥ 14). (B) Echocar-
diography of different genotypes (n = 3–8). (C) Masson's trichrome stained heart. Bar, 50 µm. (D) Normalized oxygen consumption rates (OCR) of isolated 
heart mitochondria (≥10 wk; n = 3–5). (E) Respiratory control ratios (n = 3–5). (F) ATP levels in heart (n = 6). (G) Normalized oxidized glutathione levels of 
13–14-wk-old hearts (n = 5). (H) Normalized oxidized/reduced glutathione ratio. Increased level in mutants (n = 8) over the wild type (n = 7) is abolished 
in dm hearts (n = 3). (I and J) Ubiquitin protein blots of 4- (I) and 13–14- (J) wk-old heart mitochondria. Error bars = SEM. P-values reflect comparisons to 
the wild type unless otherwise noted: ^, P ≤ 0.05; *, P ≤ 0.01; **, P ≤ 0.001. Ant A, complex III inhibitor; CCCP, uncoupler; EF, ejection fraction; Endo, 
endogenous; FS, fractional shortening; Oligo, ATPase inhibitor; WT, wild type.
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tochondria not only have restored respiration, but they also con-
sistently demonstrate oxygen consumption rates exceeding those 
of wild-type mitochondria (Fig. 3 D). As expected, dm respira-
tory control ratios and ATP levels are normal (Fig. 3, E and F).
Metabolomics analysis of 13–14-wk-old hearts reveals an 
increased level of oxidized glutathione in Mff mutants (Fig. 3 G). 
Fluorometric measurements of the oxidized/reduced glutathione 
ratio (GSSG/GSH) confirm this shift toward oxidation (Fig. 3 H). 
Because glutathione is one of the key redox regulators in the 
heart, this change implies increased oxidative stress (Chen and 
Zweier, 2014). dm hearts have GSSG/GSH ratios similar to those 
of wild-type hearts. Ubiquitination, a common response to oxida-
tive stress and first step in both proteasome-mediated protein deg-
radation and mitophagy, is also increased in Mffgt mitochondria 
(Fig. 3, I and J). Significantly, this difference can be seen at 4 wk 
of age and therefore precedes myocardial contractile dysfunction.
Multiple lines of evidence suggest that there is a general-
ized loss of mitochondrial density and integrity in Mffgt hearts. 
Quantitative EM analysis reveals a reduction in the area occupied 
by mitochondria to 68% of that in wild-type cells (Fig. 4, A and 
B). The HSP60 (mitochondrial)/actin (cytoplasmic) protein ratio 
shows a drop in mitochondrial protein content to 55% of the wild 
type in 13–14-wk-old Mff mutants (Fig. 4 C). The TOM20/actin 
ratio confirms this reduction (Fig. S3 A). Quantitative real-time 
PCR reveals an age-dependent decrease in mtDNA molecules per 
Mffgt cell (Fig. 4 D and Fig. S3 B). EM images show an increase 
in structurally compromised mitochondria, with internal vacuoliza-
tion along with both early and late stage mitophagy intermediates 
(Fig. 4 E). Revealingly, LC3 and p62 puncta are increased in Mffgt 
heart and colocalize with mitochondria (Fig. 4 F). Collectively, the 
findings of reduced mitochondrial density, protein and mtDNA 
coupled with increased ubiquitination, and LC3 and p62 puncta 
strongly suggest that mitophagy is elevated in Mffgt cardiomyo-
cytes. Consistent with their normal heart function, dm animals ex-
hibit low levels of ubiquitination, no LC3 or p62 puncta, along with 
partial normalization of mitochondrial protein (Figs. 3 J; 4, C and 
F; and S3 A). Interestingly, mitochondrial area and mtDNA levels 
are actually elevated in dm hearts (Fig. 4, A, B, and D).
Rescue of mutant phenotypes is 
tissue specific
In Mffgt heart, retuning of mitochondrial dynamics to an al-
ternative but optimal equilibrium dramatically restores tissue 
integrity and mitochondrial function. However, each tissue or 
organ has its own metabolic requirements, and we wondered 
whether there would be tissue-specific effects. The presence of 
multiple tissue defects in Mff, Mfn1, and Mfn2 mutants allows 
us to examine this issue.
The livers in Mff mutants are consistently smaller than 
wild-type livers, even when normalized to body weight 
(Fig.  5  A). The discrepancy in liver mass increases with age 
and is associated with greatly elevated alanine aminotransferase 
(ALT) levels, an indicator of hepatocyte injury (Fig. 5 B). dm 
mice have normal levels of ALT, and their liver size is midway 
between that of wild-type and mutant animals. Therefore, in 
liver as in heart, Mfn1 deficiency compensates for the loss of 
Mff. However, targeted deletion of Mfn2 in Mffgt liver by Alb-Cre 
(Postic et al., 1999) does not rescue liver size (Fig. S3 C).
Although mutation of Mff rescues the perinatal lethality of 
Mfn1loxP/loxP,Sox2-Cre mice (Fig. S2 E), it does not rescue two 
other mitofusin phenotypes. Whereas wild-type and Mffgt testes 
are equivalent in size when adjusted for body mass, those of dm 
mice are much smaller (Fig. 5 C). Histological analysis reveals 
severe degeneration of the testis in dm mice (Fig. 5 D). Because 
Mfn1loxP/loxP,Sox2-Cre mice die before puberty, their testes could 
not be examined. Instead, we used the testis-specific Stra8-Cre 
(Sadate-Ngatchou et al., 2008) to create Mfn1-deficient testes. 
Indeed, these testes are also greatly decreased in size (Fig. 5 E). 
Importantly, Mffgt,Mfn1loxP/−,Stra8-Cre testes are indistinguish-
able from Mfn1loxP/loxP,Stra8-Cre testes (Fig.  5  F), confirming 
that the testis defect in dm mice is a result of loss of Mfn1 and 
cannot be rescued by disruption of Mff.
Elimination of Mfn2 in cerebellar Purkinje cells (PCs) by 
L7-Cre results in cell death by 3 mo of age (Chen et al., 2007). 
Genetically combining Mfn2 and Mff mutations did not prevent 
loss of PCs (Fig.  5  G). Interestingly, Mffgt PCs are viable, in 
direct contrast to Drp1−/− PCs (Wakabayashi et al., 2009).
Summary
Our results indicate that Mffgt cardiomyocytes have reductions 
in mitochondrial density, protein and mtDNA associated with 
increased mitophagy, and decreased respiratory complex activ-
ity. These features lead to an eventual reduction in cardiac ATP 
levels. We suspect that this energy deficiency promotes cardio-
myocyte cell death, leading to fibrosis and heart failure.
Moreover, our results show that the balance between mito-
chondrial fusion and fission is critical for maintaining myocardium 
integrity and mitochondrial physiology. As one of several Drp1 re-
ceptors, Mff disruption, compared with Drp1 deletion, generates a 
partial fission defect (Losón et al., 2013), a feature that may be nec-
essary for functional rescue. By combining Mffgt with heterozygous 
or homozygous mutations in Mfn1 or Mfn2, we generated an allelic 
series in which the level of mitochondrial fusion can be varied, re-
sulting in differing degrees of rescue. In the most optimal genetic 
combination, we obtained full restoration of myocardial integrity, 
contractility, and respiratory chain activity. These observations in-
dicate that multiple equilibria for mitochondrial fusion and fission 
are compatible with tissue and cellular function. As in the heart, 
Mfn and Mff mutations can work in concert to protect the liver from 
damage caused by Mff disruption. However, such patterns of phe-
notypic rescue were not observed in the testis or cerebellum.
These results suggest that pharmacological inhibition 
of mitochondrial fusion or fission has the potential to restore 
tissue function in a pathological state caused by reduction of 
the opposing process. However, our results also caution that the 
degree of therapeutic benefit is likely to be context dependent 
and will depend critically on precisely fine-tuning the balance 
between fusion and fission.
Materials and methods
Mouse experiments
The Mff gene trap embryonic stem cell clone (Wellcome Trust Sanger In-
stitute) was microinjected into mouse blastocysts by the Mutant Mouse 
Resource and Research Centers. Germline transmission was evaluated 
by coat color, and the resulting line was confirmed by PCR analysis and 
DNA sequencing of the gene trap insertion site. Mice were maintained on 
a mixed 129P2,OlaHsd,C57BL/6J background. Female Mffgt/+,Mfn1loxP/loxP 
× male Mffgt/+,Mfn1+/−,Sox2Cre matings were used to generate Mffgt, 
Mfn1loxP/−,Sox2-Cre animals (termed dm for double mutant). Mfn1− is a 
null allele that contains a deletion of the G1 and G2 motifs of the GTPase 
domain (Chen et al., 2003). Mfn1loxP is a conditional allele in which loxP 
sites flank exon 4 (Chen et al., 2007). Sox2-Cre is a transgenic line with 
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Cre under the control of the Sox2 regulatory sequence (Hayashi et al., 
2002). Mouse experiments were conducted under protocols approved by 
the Caltech Institutional Animal Care and Use Committee.
Physiological measurements were performed on 13−14-wk-old 
mice. Body temperature was measured with a rectal probe, using the 
Thermalert Monitoring Thermometer (Braintree Scientific). To obtain 
blood measurements, cardiac puncture was performed on mice anesthe-
tized with isoflurane, and the blood was analyzed with the iSTAT sys-
tem (Abbott). Mice were exercised by swimming for 20 min at ∼37°C 
before being anesthetized. The grasp test was performed by having 
mice grasp onto a wire rack and then inverting the rack over a padded 
surface. Mice were allowed to move around the rack freely. Time was 
counted from inversion until the mouse released all four paws or 5 min 
was reached, whichever came first. Fertility was tested by mating mu-
tants to wild-type mice of the opposite sex and counting days from 
cohabitation until a litter was born. Controls were Mffgt/+ crosses.
Sperm count
Both caudal epididymes were minced in 3 ml of prewarmed PBS and 
returned to 37°C for 15 min to allow sperm to swim out. The solution 
was titurated, and 1 ml was removed to a microfuge tube to sit over-
night for sperm to stop swimming before counting on a hemocytometer.
Figure 4. Loss of mitochondria in Mffgt myocardium. (A) Low-magnification EM showing differences in mitochondrial mass. Bars, 5 µm. (B) Quantification 
of mitochondrial area in EM images. (C) HSP60/actin protein ratio, normalized to wild type (n ≥ 7). (D) mtDNA per cell, normalized to wild-type content 
(n ≥ 7). (E) EM of mutant myocardium, showing examples of defective mitochondria. Arrow indicates mitophagic structure. Bars, 0.5 µm. (F) Heart sections 
immunostained with LC3 or p62 (red) and HSP60 (green). Arrows indicate positive puncta. Mutant inset is enlarged. Bars: 10 µm; (mutant inset) 50 µm. 
Error bars = SEM. P-values as compared with wild type: ^, P ≤ 0.05; *, P ≤ 0.01; **, P ≤ 0.001. nDNA, nuclear DNA; WT, wild type.
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Echocardiography
Animals were anesthetized with isoflurane (1.5% induce and main-
tenance) and placed on a temperature-controlled table (40°C) while 
maintaining a heart rate of ∼500 beats per minute. Hair was removed 
from the chest with a hair removal cream (Veet; Reckitt Benckiser), and 
preheated ultrasound transmission gel was applied. Echocardiograms 
were performed with a high-resolution ultrasound instrument (Vevo 
2100; VisualSonics, Inc.).
A parasternal long-axis B-mode image was obtained. The maximal 
long axis of the LV was positioned perpendicular to the ultrasound beam. 
A 90° rotation of the ultrasound probe at the papillary muscle level was 
performed to obtain a parasternal short-axis view of the LV. An M-mode 
image was captured to document LV dimensions. Images were saved 
and analyzed using the Vevo 2100 cardiac analysis package. Echocardio-
grams were conducted under the guidelines approved by the University 
of California, Los Angeles (UCLA), Animal Research Committee.
Figure 5. Mffgt and dm phenotypes in liver, testis, and cerebellum. (A) Comparison of liver to body mass ratio (n ≥ 10). (B) ALT levels in serum (n = 5–13). (C 
and E) Testis to body mass ratio in Mffgt and dm (C; n ≥ 5) and Stra8-Cre lines (E; n ≥ 6). (D and F) Hematoxylin and eosin stain of testicular cross sections in 
8–9-wk-old Mffgt and dm (D) and Stra8-Cre lines (F). Note that only control and Mffgt sections contain spermatozoa (arrows). (G) Anticalbindin immunofluores- 
cence illuminating cerebellar PC. Error bars = SEM. P-values as compared with the wild type: ^ , P ≤ 0.05; *, P ≤ 0.01; **, P ≤ 0.001. Bars, 50 µm. WT, wild type.
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Antibodies for Western blots
Antibodies to the following proteins were used: HSP60 (goat; sc-1052; 
Santa Cruz Biotechnology, Inc.), ubiquitin (mouse; 3936P; Cell Signal-
ing Technology), actin (rabbit; A2103; Sigma-Aldrich), histone H2B 
(rabbit; IMG-359; Imgenex), Mfn1 (raised in chicken against mouse 
Mfn1 residues 348–579; Chen et al., 2003), Mfn2 (rabbit; D2D10; 
Cell Signaling Technology), Opa1 (mouse ascites produced in-house 
against the mouse S1 isoform), Fis1 (rabbit; ALX-210-1037-0100; 
Enzo Life Sciences), Drp1 (mouse; 611113; BD), and Mff (raised in 
rabbit against human Mff by A. van der Bliek, UCLA, Los Angeles, 
CA; Gandre-Babbe and van der Bliek, 2008). All secondary antibodies 
for Western blots were HRP conjugated and obtained from Jackson Im-
munoResearch Laboratories, Inc.
Histology
For hematoxylin and eosin or Masson’s trichrome staining, forma-
lin-fixed tissues were embedded in paraffin and sectioned to 5 µm. Slides 
were dewaxed and rehydrated. For hematoxylin/eosin, slides were 
stained with Harris-modified hematoxylin, blued with 0.1% NH4OH, 
stained with eosin, dehydrated, and cover-slipped in xylene-based 
mounting medium. Trichrome stain was performed according to in-
structions from the WebPath Internet Pathology Laboratory (The Uni-
versity of Utah Eccles Health Sciences Library). TUN EL analysis was 
performed according to the manufacturer’s instructions with the Apop-
Tag Fluorescein In situ Apoptosis Detection kit (EMD Millipore). For 
NADH/SDH/COX staining, freshly dissected tissue was embedded in 
OCT compound (Tissue-Tek), frozen on dry ice, and sectioned to 10 
µm. Staining protocols were obtained from the Washington University 
Neuromuscular Disease Center website. Because of the high mitochon-
drial content of cardiomyocytes, staining times were decreased to 10 
min, 15 min, and 10 min, respectively. Quantification was conducted 
by using ImageJ (National Institutes of Health) to mask areas without 
myofibers and to measure mean intensity in remaining pixels.
For visualization of PCs, 14-µm midsagittal cryosections of 
formalin-perfused, OCT-embedded brain were immunostained with 
anticalbindin (Sigma-Aldrich), followed by Cy3-sheep anti-mouse 
(Jackson ImmunoResearch Laboratories, Inc.).
Images were acquired using a camera (Spot RT; SPOT Imaging 
Solutions) and NIS Elements software (Nikon) on a microscope(E-
clipse E600; Nikon) at RT. Objectives (Nikon) used were Phase 10× 
(NA 0.25), Plan Fluor 20× (NA 0.5), and Plan Fluor 40× (NA 0.75). 
Photoshop (Adobe) was used only to change whole-image bright-
ness/contrast and to crop.
Cell culture and immunofluorescence
MEFs expressing mito-DsRed were grown in DMEM containing 10% 
bovine calf serum. Peroxisomes were visualized by staining for Pex14 
(rabbit; 10594–1-AP; Protein Tech) followed by a secondary anti-
body labeled with Alexa Fluor 488. Cells with any peroxisomes ≥2 
µm long were scored as having tubular peroxisomes. Wild-type and 
Mff patient fibroblasts were provided by F. Alkuraya (Alfaisal Univer-
sity, Riyadh, Saudi Arabia).
For LC3 (rabbit; 2775; Cell Signaling Technology), P62 (rab-
bit; PM045; MBL), and PEX14 (rabbit; 10594–1-AP; Protein Tech) 
immunofluorescence, 10-µm cryosections of formalin-perfused, OCT- 
embedded heart was immunostained with the relevant antibodies and 
an Alexa Fluor 546–labeled donkey anti-rabbit (Life Technologies) 
secondary. HSP60 (sc-1052; Santa Cruz Biotechnology, Inc.) was visu-
alized with Alexa Fluor 488–labeled donkey anti-goat.
Images were acquired using Zen 2009 software (Carl Zeiss) on a 
confocal microscope (LSM710; Carl Zeiss) at RT. A Plan-Apochromat 
63×/1.4 oil objective was used. Photoshop was used only to change 
whole-image brightness/contrast and to crop.
EM analysis
Mice were perfused with 3% paraformaldehyde, 1.5% glutaralde-
hyde, 100-mM cacodylate, 5-mM CaCl2, and 2.5% sucrose, pH 
7.4. Dissected LV tissue was postfixed for 2 h. The papillary mus-
cle was removed and trimmed into small 1 × 2-mm3 pieces. Sam-
ples were postfixed in Palade’s OsO4, en bloc stained in Kellenberger 
uranyl acetate, dehydrated through a graded series of EtOH, and flat 
embedded in EMB ED 812 (EMS). 80-nm longitudinal sections of 
papillary muscle were prepared on an ultramicrotome (UCT; Leica), 
collected onto 400 mesh high-transmission nickel grids, and post-
stained with lead citrate and uranyl acetate. Images were collected 
with a transmission electron microscope (Tecnai 12; FEI) operating at 
100 kV and equipped with an Olympus Soft Imaging System (OSIS) 
digital camera (Megaview III; Olympus). 8-bit TIFF images were 
subsequently exported from the OSIS iTEM database, and figures 
were assembled in Photoshop with only linear adjustments made in 
brightness and contrast.
To quantify mitochondrial length, the freehand line tool avail-
able in the OSIS iTEM software (version 5.0; Olympus) was used to 
measure the lengths of hundreds of mitochondria for each genotype. 
To quantify mitochondrial area, eight random images were captured 
at a magnification of 4,900. The total cardiac muscle area and total 
mitochondrial area were determined using the freehand polygon line 
tool in the OSIS iTEM software (version 5.0). The percent ratio of 
total mitochondrial area versus total cardiac muscle area was calcu-
lated for each genotype.
Cellular respiration
Mitochondria were isolated from heart in MSHE (70-mM sucrose, 
220-mM mannitol, 10-mM Hepes, 1-mM EGTA, and 0.5% BSA, pH 
7.2). Tissue was minced with a tissue homogenizer (Polytron; VWR) 
and centrifuged twice at 800 g to remove cellular debris. The mito-
chondrial fraction was isolated with an 8,500 g spin, and the pellet was 
resuspended and spun a second time. The final pellet was resuspended 
in 50 µl MSHE, and protein quantification was performed. Mitochon-
dria were diluted in MAS/PM (70-mM sucrose, 220-mM mannitol, 
10-mM Hepes, 1-mM EGTA, 0.2% BSA, 10-mM KH2PO4, 5-mM 
MgCl2, pH 7.2, 5-mM pyruvate, and 2.5-mM malate), plated at 0.8 µg/
well, and analyzed on the XF96 Extracellular Flux Analyzer (Seahorse 
Bioscience). Drugs added were 4-mM ADP, 5-µM oligomycin, 5-µM 
CCCP, and 5-µM antimycin A.
Biochemical measurements
The following measurements were performed according to the man-
ufacturer’s instructions: ATP Colorimetric Assay kit (BioVision) with 
Deproteinizing Sample Preparation kit (BioVision); GSH/GSSG Ratio 
Detection Assay kit (Fluorometric green; Abcam), and ALT Reagent 
(Colorimetric, Endpoint Method; BQ kits).
mtDNA quantification
To quantify the amount of mtDNA per nuclear genome, we used the 
following primers: mtDNA forward primer, 5′-CCT ATCAC CCTTG 
CCATC AT-3′; mtDNA reverse primer, 5′-GAG GCTGT TGCTT GTGTG 
 AC-3′; nuclear DNA (Pecam) forward primer, 5′-ATG GAAAG 
CCTGC CATCA TG-3′; and nuclear DNA (Pecam) reverse primer, 
5′-TCC TTGTT GTTCA GCATC AC-3′. Quantification of relative copy 
number differences was performed using the difference in threshold 
amplification between mtDNA and nuclear DNA (ΔΔC(t) method).
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Metabolite profiling
Three distinct liquid chromatography tandem mass spectrometry meth-
ods were used to measure polar metabolites and lipids in plasma and 
heart homogenates. Negative ionization mode polar metabolite pro-
filing data were acquired using an ACQ UITY UPLC (Waters Corp.) 
coupled to a 5500 QTR AP triple quadrupole mass spectrometer (AB 
SCI EX). Plasma or tissue homogenate samples (30 µl) were extracted 
using 120  µl of 80% methanol containing 0.05 ng/µl inosine-[15N]4, 
0.05 ng/µl thymine-d4, and 0.1 ng/µl glycocholate-d4 as internal stan-
dards (Cambridge Isotope Laboratories, Inc.). The samples were cen-
trifuged (10 min at 9,000  g and 4°C), and the supernatants (10  µl) 
were injected directly onto a 150 × 2.0-mm column (Luna NH2; Phe-
nomenex). The column was eluted at a flow rate of 400 µl/min with 
initial conditions of 10% mobile phase A (20-mM ammonium acetate 
and 20-mM ammonium hydroxide in water) and 90% mobile phase B 
(10-mM ammonium hydroxide in 75:25 vol/vol acetonitrile/methanol), 
followed by a 10-min linear gradient to 100% mobile phase A.  The 
ion spray voltage was −4.5 kV and the source temperature was 500°C.
Positive ionization mode polar metabolite data were acquired 
using a 4000 QTR AP triple quadrupole mass spectrometer (AB SCI 
EX) coupled to a binary HPLC pump (1200 Series; Agilent Technol-
ogies) and an autosampler (HTS PAL; Leap Technologies). 10 µl of 
plasma or tissue homogenate samples was extracted using nine vol-
umes of 74.9:24.9:0.2 (vol/vol/vol) acetonitrile/methanol/formic acid 
containing stable isotope-labeled internal standards (0.2 ng/µl valine-d8 
[Isotec]; and 0.2 ng/µl phenylalanine-d8 [Cambridge Isotope Labora-
tories, Inc.]). The samples were centrifuged (10 min at 9,000  g and 
4°C), and the supernatants (10 µl) were injected onto a 150 × 2.1-mm 
column (Atlantis HIL IC; Waters Corp.). The column was eluted isoc-
ratically at a flow rate of 250 µl/min with 5% mobile phase A (10-mM 
ammonium formate and 0.1% formic acid in water) for 1 min, followed 
by a linear gradient to 40% mobile phase B (acetonitrile with 0.1% 
formic acid) over 10 min. The ion spray voltage was 4.5 kV, and the 
source temperature was 450°C.
Analyses of polar and nonpolar lipids were conducted using an 
Open Accela 1250 ultra (U)-HPLC and a hybrid quadrupole orbitrap 
mass spectrometer (Q Exactive; Thermo Fisher Scientific). 10  µl 
plasma or heart homogenate samples were prepared with the addition 
of 190 µl isopropanol containing 1-dodecanoyl-2-tridecanoyl-sn-glyc-
ero-3-phosphocholine (Avanti Polar Lipids) as an internal standard, 
followed by centrifugation at 9,000 g for 15 min. 10-µl samples were 
injected onto a 150 × 3.0-mm column (Prosphere HP C4; Grace). The 
column was eluted isocratically with 80% mobile phase A (95:5:0.1 
vol/vol/vol 10-mM ammonium acetate/methanol/acetic acid) for 2 min, 
followed by a linear gradient to 80% mobile phase B (99.9:0.1 vol/vol 
methanol/acetic acid) over 1 min, a linear gradient to 100% mobile 
phase B over 12 min, and then 10 min at 100% mobile phase B. Mass 
spectrometry (MS) data were acquired in the positive ion mode using 
electrospray ionization and full scan MS over mass-to-charge ratio 
400–1,100. Other MS settings were spray voltage, 3 kV; capillary tem-
perature, 300°C; sheath gas, 50 arbitrary units; auxiliary gas, 15 arbi-
trary units; heater temperature, 300°C; S-lens level, 60; and resolution, 
70,000. Raw data were integrated and visually inspected using Multi-
Quant 1.2 software (AB SCI EX) for polar metabolites and TraceFinder 
3.0 software (Thermo Fisher Scientific) for lipids.
Online supplemental material
Fig. S1 shows the gene trap locus, loss of Mff protein in the mutant, 
and a variety of Mff mutant phenotypes. The phenotypes include 
small size, low weight, malocclusion, kyphosis, grip weakness, 
reduced fertility, and reduced sperm count. Fig. S2 shows additional 
characterization of Mff mutants. Fig. S3 shows the effect of Mfn1 or 
Mfn2 mutations. Video 1 shows the gait alterations in the Mff mutant. 
Online supplemental material is available at http ://www .jcb .org /cgi /
content /full /jcb .201507035 /DC1.
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